Back to Selection     Print       Date : 31 Jul 2026
Fund Summary
UTI Healthcare Fund (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 28-Jun-99
Corpus(Cr.) 1371.0 Latest NAV 341.3169 As on 11-09-2026
Equity(%) 97.06 52 Week High 344.93
Debt(%) 2.94 52 Week Low 268.586
Others(%) 0.0 Exit Load 1% for redemption within 30 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 1.84
Scheme Benchmark BSE Healthcare TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Kamal Gada
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 26.62%
Top 10 Holdings 42.76%
Top 25 Holdings 77.43%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 69.47
Healthcare 24.97
Cash 2.92
Chemicals 1.71
FMCG 0.91
Others 0.02
 
 
 
 
 
Portfolio Metrics
PB Ratio 5.59
PE Ratio 42.65
 
Top 25 Holdings
Holdings Net Asset(%)
Sun Pharmaceutical Industries Ltd. 8.71
Divis Laboratories Ltd. 5.57
Ajanta Pharma Ltd. 4.80
Caplin Point Laboratories Ltd. 3.95
Lupin Ltd 3.59
Gland Pharma Limited 3.56
Apollo Hospitals Enterprises Ltd. 3.46
Alkem Laboratories Limited 3.10
Dr. Reddys Laboratories Ltd. 3.10
NET CURRENT ASSETS 2.92
Global Health Limited 2.81
Max Healthcare Institute Limited 2.76
Ipca Laboratories Ltd. 2.68
Fortis Healthcare Ltd 2.58
Anthem Biosciences Limited 2.50
PROCTER & GAMBLE HEALTH LIMITED 2.41
Rainbow Childrens Medicare Limited 2.34
Sai Life Sciences Limited 2.20
EQ- JUPITER LIFE LINE HOSPITALS LTD 2.18
Cohance Lifesciences Limited 2.17
Marksans Pharma Ltd. 2.17
Glenmark Pharmaceuticals ltd 2.11
VIYASH SCIENTIFIC LIMITED 1.98
Aster DM Healthcare Limited 1.94
Aurobindo Pharma Ltd. 1.84

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
0.02% 9.06% 23.38% 15.18%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
-3.94% -0.40% 1.90% -5.82%
 
Scheme Benchmark [NSE - Nifty Healthcare TRI]
-0.08% 6.28% 13.28% 12.39%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
8.63% 22.79% 14.90% 13.74%
 
 
-2.82% 6.50% 7.42% 11.72%
 
 
6.54% 19.92% 13.28% 10.77%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
UTI Healthcare Fund (G) 15.91% 1.2280 11.1645% 42.6052 0.1573
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
UTI Healthcare Fund (G) 18.0481% 0.0003 0.3232 14.2549 1.4781
 
Back to Selection